These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29521683)

  • 1. Body mass index and prostate cancer risk in the Carotene and Retinol Efficacy Trial.
    Bonn SE; Barnett MJ; Thornquist M; Goodman G; Neuhouser ML
    Eur J Cancer Prev; 2019 May; 28(3):212-219. PubMed ID: 29521683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial.
    Neuhouser ML; Barnett MJ; Kristal AR; Ambrosone CB; King IB; Thornquist M; Goodman GG
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2202-6. PubMed ID: 19661078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial.
    Omenn GS; Goodman GE; Thornquist MD; Balmes J; Cullen MR; Glass A; Keogh JP; Meyskens FL; Valanis B; Williams JH; Barnhart S; Cherniack MG; Brodkin CA; Hammar S
    J Natl Cancer Inst; 1996 Nov; 88(21):1550-9. PubMed ID: 8901853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.
    Kirsh VA; Hayes RB; Mayne ST; Chatterjee N; Subar AF; Dixon LB; Albanes D; Andriole GL; Urban DA; Peters U;
    J Natl Cancer Inst; 2006 Feb; 98(4):245-54. PubMed ID: 16478743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival.
    Watters JL; Gail MH; Weinstein SJ; Virtamo J; Albanes D
    Cancer Res; 2009 May; 69(9):3833-41. PubMed ID: 19383902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.
    Goodman GE; Thornquist MD; Balmes J; Cullen MR; Meyskens FL; Omenn GS; Valanis B; Williams JH
    J Natl Cancer Inst; 2004 Dec; 96(23):1743-50. PubMed ID: 15572756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the beta-carotene and retinol efficacy trial (CARET).
    Neuhouser ML; Patterson RE; Thornquist MD; Omenn GS; King IB; Goodman GE
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):350-8. PubMed ID: 12692110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
    Goodman GE; Schaffer S; Omenn GS; Chen C; King I
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated intake of vitamin D and its interaction with vitamin A on lung cancer risk among smokers.
    Cheng TY; Goodman GE; Thornquist MD; Barnett MJ; Beresford SA; LaCroix AZ; Zheng Y; Neuhouser ML
    Int J Cancer; 2014 Nov; 135(9):2135-45. PubMed ID: 24622914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Carotene Supplementation and Lung Cancer Incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: The Role of Tar and Nicotine.
    Middha P; Weinstein SJ; Männistö S; Albanes D; Mondul AM
    Nicotine Tob Res; 2019 Jul; 21(8):1045-1050. PubMed ID: 29889248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET).
    Thornquist MD; Omenn GS; Goodman GE; Grizzle JE; Rosenstock L; Barnhart S; Anderson GL; Hammar S; Balmes J; Cherniack M
    Control Clin Trials; 1993 Aug; 14(4):308-24. PubMed ID: 8365195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.
    Omenn GS; Goodman G; Thornquist M; Grizzle J; Rosenstock L; Barnhart S; Balmes J; Cherniack MG; Cullen MR; Glass A
    Cancer Res; 1994 Apr; 54(7 Suppl):2038s-2043s. PubMed ID: 8137335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Leitzmann MF; Ahn J; Albanes D; Hsing AW; Schatzkin A; Chang SC; Huang WY; Weiss JM; Danforth KN; Grubb RL; Andriole GL;
    Cancer Causes Control; 2008 Dec; 19(10):1267-76. PubMed ID: 18618278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands).
    Schuurman AG; Goldbohm RA; Brants HA; van den Brandt PA
    Cancer Causes Control; 2002 Aug; 13(6):573-82. PubMed ID: 12195647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin A and beta (β)-carotene supplementation for cystic fibrosis.
    de Vries JJ; Chang AB; Bonifant CM; Shevill E; Marchant JM
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006751. PubMed ID: 30091146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary and serum alpha-tocopherol, beta-carotene and retinol, and risk for colorectal cancer in male smokers.
    Malila N; Virtamo J; Virtanen M; Pietinen P; Albanes D; Teppo L
    Eur J Clin Nutr; 2002 Jul; 56(7):615-21. PubMed ID: 12080400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers.
    Goodman GE; Omenn GS; Thornquist MD; Lund B; Metch B; Gylys-Colwell I
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):389-96. PubMed ID: 8348063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between male pattern baldness and the risk of aggressive prostate cancer: an analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Zhou CK; Pfeiffer RM; Cleary SD; Hoffman HJ; Levine PH; Chu LW; Hsing AW; Cook MB
    J Clin Oncol; 2015 Feb; 33(5):419-25. PubMed ID: 25225425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.
    Kelly SP; Graubard BI; Andreotti G; Younes N; Cleary SD; Cook MB
    J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 27754927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.